Forest Laboratories, Inc., Gedeon Richter Ltd. May Do Additional Phase II Cariprazine Trial; Drug Misses Overall Goal

Published: Aug 30, 2010

Bloomberg -- Gedeon Richter Nyrt., Hungary’s largest drugmaker, said that the Phase II clinical trial of Cariprazine for bipolar depression produced no “statistically significant” result compared with placebo treatment.

Back to news